Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
Carlyle Group Targets First Buyout Fund Close as $200 Billion Fundraising Push Takes Shapemarketbeat.com
Carlyle Group (NASDAQ:CG) expects its next U.S. buyout fund to reach an initial close this quarter or next, as the firm prepares for a busy fundraising cycle across private equity, credit and secondaries, Co-President and Head of Private Equity John Redett said.
Redett said he felt good about the p
Via MarketBeat · November 10, 2026
Verastem Targets Accelerated Approval for Pancreatic Cancer Drug, Expands Trial Plansmarketbeat.com
Verastem (NASDAQ:VSTM) is advancing its experimental KRAS G12D inhibitor VS-7375 toward potential accelerated approval in pancreatic cancer, with plans to expand studies in colorectal and lung cancers, company executives said at an investor event.
Vice President of Development Ting Wu said Verastem
Via MarketBeat · November 10, 2026
ZipRecruiter Q3 Earnings Call Highlightsmarketbeat.com
ZipRecruiter (NYSE:ZIP) reported third-quarter revenue growth of 8% and expanded profitability as more employers paid to use its hiring marketplace and engagement increased among job seekers.
Revenue rose to $124.4 million for the quarter ended September 30, 2026, at the top end of the company’s gu
Via MarketBeat · November 10, 2026
WELL Health Technologies Q3 Earnings Call Highlightsmarketbeat.com
WELL Health Technologies (TSE:WELL) expects 2026 revenue of approximately CAD 1.58 billion, at the low end of its previous guidance range, after slowing acquisitions in the second half of the year to focus on integrating earlier deals.
On its third-quarter earnings call, Chairman and CEO Hamed Shah
Via MarketBeat · November 10, 2026
Celldex Therapeutics Targets 2027 Filing for Barzolvolimab After Phase 3 Resultsmarketbeat.com
Celldex Therapeutics (NASDAQ:CLDX) plans to submit a biologics license application for barzolvolimab in 2027, using full 52-week data from its Phase 3 studies in chronic spontaneous urticaria, executives said at Guggenheim’s 3rd Annual Healthcare Innovation Conference.
The company expects to presen
Via MarketBeat · November 10, 2026
What Zeta Global (ZETA) Said on Its Q3 Earnings Callmarketbeat.com
Zeta Global (NYSE:ZETA) reported third-quarter 2026 revenue of $493 million, up 46% from a year earlier, and raised its full-year outlook as customers increased their use of its artificial intelligence tools.
Revenue grew 30% excluding Marigold and political candidate revenue, accelerating from 28%
Via MarketBeat · November 10, 2026
Skydance Q3 Earnings Call Highlightsmarketbeat.com
Skydance (NYSE:SKYD) executives outlined plans to combine streaming services, cut costs and reduce debt following the launch of the combined company, while warning that an underperforming Warner Bros. film slate will weigh on fourth-quarter results.
On its third-quarter earnings call, the company s
Via MarketBeat · November 10, 2026
What Nerdy (NRDY) Said on Its Q3 Earnings Callmarketbeat.com
Nerdy (NYSE:NRDY) reported lower third-quarter revenue and active membership as delays in product launches limited customer acquisition during the back-to-school season. The online learning company said the smaller membership base will weigh on fourth-quarter revenue, even as cost reductions helped
Via MarketBeat · November 10, 2026
Cybin Expects Key Phase III Depression Trial Results This Quartermarketbeat.com
Helus Pharma expects results from the first Phase III trial of its experimental adjunctive treatment for major depressive disorder later this quarter, CEO Michael Halstead said at the Guggenheim Healthcare Innovation Conference.
The company’s 003 program, a deuterated psilocin treatment, is being s
Via MarketBeat · November 10, 2026
Radiant Logistics Q1 Earnings Call Highlightsmarketbeat.com
Radiant Logistics (NYSEAMERICAN:RLGT) reported higher revenue and earnings for its fiscal first quarter, as strength in U.S. freight services and disaster-relief air shipments helped lift adjusted EBITDA.
Revenue for the quarter ended Sept. 30, 2026, rose to $279.8 million from $226.7 million a yea
Via MarketBeat · November 10, 2026
Securitize Q3 Earnings Call Highlightsmarketbeat.com
Securitize (NYSE:SECZ) reported a 13% increase in third-quarter revenue as growth in its tokenization business helped offset a decline in asset servicing. The company maintained its full-year revenue outlook and announced a planned acquisition intended to expand its role in credit origination.
Reve
Via MarketBeat · November 10, 2026
H&R Block Q1 Earnings Call Highlightsmarketbeat.com
H&R Block (NYSE:HRB) reported a 10.2% increase in fiscal first-quarter revenue and reaffirmed its full-year outlook, as the tax preparer prepares to expand a test of a more consultative service model ahead of the 2027 tax season.
Revenue rose to $224.3 million in the quarter, an increase of $20
Via MarketBeat · November 10, 2026
Onto Innovation Q3 Earnings Call Highlightsmarketbeat.com
Onto Innovation (NYSE:ONTO) reported third-quarter revenue of $410 million, up 19% from the previous quarter and nearly 90% from a year earlier, as demand for semiconductor inspection and metrology equipment fueled growth across advanced packaging and chipmaking markets.
The company raised its four
Via MarketBeat · November 10, 2026
What Exodus Movement (EXOD) Said on Its Q3 Earnings Callmarketbeat.com
Exodus Movement (NYSEAMERICAN:EXOD) reported higher third-quarter revenue and a narrower adjusted EBITDA loss as the digital asset wallet provider integrated its acquired payments businesses and reduced costs.
Revenue rose to $32.5 million from $26.2 million in the second quarter and $30.3 million
Via MarketBeat · November 10, 2026
What Myomo (MYO) Said on Its Q3 Earnings Callmarketbeat.com
Myomo (NYSEAMERICAN:MYO) reported record third-quarter revenue of $12.3 million, up 22% from a year earlier, and narrowed its full-year revenue guidance as referrals and higher sales of its powered arm braces helped improve operating performance.
The company reached approximately break-even adjuste
Via MarketBeat · November 10, 2026
What Hims & Hers Health (HIMS) Said on Its Q3 Earnings Callmarketbeat.com
Hims & Hers Health (NYSE:HIMS) reported third-quarter revenue growth of 49% but lost 100,000 subscribers from the prior quarter, as the digital health company held back U.S. weight-loss marketing and consolidated brands in international markets.
Revenue rose to $890 million, while subscribers i
Via MarketBeat · November 10, 2026
What Babcock (BW) Said on Its Q3 Earnings Callmarketbeat.com
Babcock (NYSE:BW), formally Babcock & Wilcox Enterprises, reported third-quarter 2026 revenue of $290.8 million, more than double the year-earlier figure, as large power-generation projects contributed to growth. The company reaffirmed its full-year adjusted EBITDA target and issued a higher tar
Via MarketBeat · November 10, 2026
What Clearway Energy (CWEN) Said on Its Q3 Earnings Callmarketbeat.com
Clearway Energy (NYSE:CWEN) reported third-quarter cash available for distribution of $173 million and introduced a 2031 growth target, saying committed investments, fleet upgrades and a growing project pipeline support its long-term outlook.
The power producer reaffirmed its revised 2026 cash avai
Via MarketBeat · November 9, 2026
What BTGO (BTGO) Said on Its Q3 Earnings Callmarketbeat.com
BitGo Holdings, BTGO (NYSE:BTGO), reported a 50.9% year-over-year decline in third-quarter revenue as weaker digital asset trading and a shift toward lower-margin stablecoin transactions weighed on results. The company posted net income of $44.1 million, helped by an unrealized gain on digital asset
Via MarketBeat · November 9, 2026
Axsome Therapeutics Tops $1 Billion Revenue Run Rate as AUVELITY Sales Surgemarketbeat.com
Axsome Therapeutics (NASDAQ:AXSM) reported $260 million in third-quarter revenue, driven by growth in its AUVELITY treatment for major depressive disorder and Alzheimer’s disease agitation, executives said at the Guggenheim Healthcare Innovation Conference.
Chief Financial Officer Nick Pizzie said
Via MarketBeat · November 9, 2026
What Cannae (CNNE) Said on Its Q3 Earnings Callmarketbeat.com
Cannae (NYSE:CNNE) reported lower third-quarter revenue as it continued shifting its portfolio toward sports and entertainment, closing O’Charley’s restaurants and returning capital to shareholders through buybacks and dividends.
The investment company reported operating revenue of $68 million, dow
Via MarketBeat · November 9, 2026
What Bakkt (BKKT) Said on Its Q3 Earnings Callmarketbeat.com
Bakkt (NYSE:BKKT) reiterated its full-year transaction volume target and set a goal for the first half of 2027, as executives said the company’s growth plans depend on institutional and cross-border clients completing integrations and increasing their use of its platform.
On its third-quarter 2026
Via MarketBeat · November 9, 2026
What Csquare (CSQR) Said on Its Q3 Earnings Callmarketbeat.com
Csquare (NYSE:CSQR) reported 25.6% revenue growth in the third quarter of 2026 as strong bookings and pricing helped the data center operator expand its contracted backlog and increase adjusted earnings.
Revenue rose to $302.3 million, while adjusted EBITDA increased 44.3% from a year earlier to $1
Via MarketBeat · November 9, 2026
Repay Q3 Earnings Call Highlightsmarketbeat.com
Repay (NASDAQ:RPAY) reported a 97% increase in third-quarter revenue, helped by its KUBRA acquisition and strong political media activity, but lowered its normalized growth and free cash flow expectations as its core consumer payments business fell short of projections.
The payments company reitera
Via MarketBeat · November 9, 2026
Archer Aviation Q3 Earnings Call Highlightsmarketbeat.com
Archer Aviation (NYSE:ACHR) said its Midnight aircraft has received a Federal Aviation Administration market survey certificate for conventional takeoff and landing flights, setting the stage for operations in Los Angeles as the company works toward broader certification and passenger flights.
The
Via MarketBeat · November 9, 2026
Viant Technology Q3 Earnings Call Highlightsmarketbeat.com
Viant Technology (NASDAQ:DSP) reported third-quarter 2026 revenue growth of 29% as advertisers increased spending on connected TV, and said it expects further growth in 2027 from enterprise customers and adoption of its advertising tools.
The advertising technology company also announced the acquis
Via MarketBeat · November 9, 2026
What Life360 (LIF) Said on Its Q3 Earnings Callmarketbeat.com
Life360 (NASDAQ:LIF) reported 40% third-quarter revenue growth as its subscription business expanded and an advertising acquisition boosted sales, although advertising revenue fell short of management’s expectations.
The family safety and location-sharing company raised the low end of its full-year
Via MarketBeat · November 9, 2026
What Public Policy (PPHC) Said on Its Q3 Earnings Callmarketbeat.com
Public Policy (NASDAQ:PPHC) reported higher third-quarter revenue and adjusted earnings as demand for government relations services grew, and reaffirmed its full-year outlook following a series of acquisitions.
Revenue increased 13.2% to $55.2 million, including organic growth of 5.1%, up from 3.9%
Via MarketBeat · November 9, 2026
What Thryv (THRY) Said on Its Q3 Earnings Callmarketbeat.com
Thryv (NASDAQ:THRY) reported third-quarter software revenue of $112 million and said sales of its new Growth Platform were running ahead of plan, even as a planned sale of its print directories business and restructuring costs cloud its fourth-quarter outlook.
Chairman and CEO Joe Walsh said the co
Via MarketBeat · November 9, 2026
Bank of New York Mellon CFO Sees Growth Ahead After 15 Quarters of Sales Gainsmarketbeat.com
Bank of New York Mellon (NYSE:BNY) is looking to expand relationships with existing clients and attract new ones as it builds on a companywide operating overhaul, Chief Financial Officer Dermot McDonogh said at a BMO Capital Markets event.
Speaking with Brennan Hawken, BMO’s head of diversified fin
Via MarketBeat · November 9, 2026
What Siga Technologies (SIGA) Said on Its Q3 Earnings Callmarketbeat.com
Siga Technologies (NASDAQ:SIGA) said it continues to expect a new U.S. government procurement contract for its smallpox treatment TPOXX, although the timing remains uncertain after a slower-than-expected contracting process.
The company reported no product sales in the third quarter of 2026, follow
Via MarketBeat · November 9, 2026
Ameresco Q3 Earnings Call Highlightsmarketbeat.com
Ameresco (NYSE:AMRC) reported a 10% increase in third-quarter revenue as growth across its projects, energy assets and operations and maintenance businesses helped offset a changing accounting presentation. The energy services company also reported one of its strongest quarters for new project award
Via MarketBeat · November 9, 2026
What USA Rare Earth (USAR) Said on Its Q3 Earnings Callmarketbeat.com
USA Rare Earth (NASDAQ:USAR) reported third-quarter revenue of $3 million as shortages of critical raw materials constrained production, while executives outlined plans to ramp up rare earth output and expand magnet manufacturing in 2027.
Revenue declined from the second quarter because of shortage
Via MarketBeat · November 9, 2026
Plug Power Q3 Earnings Call Highlightsmarketbeat.com
Plug Power (NASDAQ:PLUG) reported higher revenue and a sharply narrower gross margin loss in the third quarter of 2026, while reducing net cash usage to what management called a record low. The hydrogen company reaffirmed its full-year revenue growth outlook and said it remains focused on achieving
Via MarketBeat · November 9, 2026
Rocket Lab Q3 Earnings Call Highlightsmarketbeat.com
Rocket Lab (NASDAQ:RKLB) reported record third-quarter 2026 revenue and backlog as demand for launch services and spacecraft helped offset rising spending on its Neutron rocket.
Revenue rose 73% from a year earlier to $267.8 million, above the company’s guidance of $250 million to $265 million. The
Via MarketBeat · November 9, 2026
What Take-Two Interactive Software (TTWO) Said on Its Q2 Earnings Callmarketbeat.com
Take-Two Interactive Software (NASDAQ:TTWO) reiterated its fiscal 2027 net bookings forecast even after second-quarter bookings fell short of guidance, as executives pointed to stronger-than-expected preorders for the coming release of Grand Theft Auto VI.
The video game publisher reported $1.6 bil
Via MarketBeat · November 9, 2026
Xenon Pharmaceuticals Q3 Earnings Call Highlightsmarketbeat.com
Xenon Pharmaceuticals (NASDAQ:XENE) expects pivotal depression study results in December, earlier than previously projected, while preparing for a potential U.S. launch of its lead epilepsy drug and advancing two pain treatments into midstage testing.
On its third-quarter 2026 earnings call, the co
Via MarketBeat · November 9, 2026
CAMP4 Therapeutics Targets First SYNGAP1 Data in 2028 as Patient Dosing Nearsmarketbeat.com
CAMP4 Therapeutics (NASDAQ:CAMP) expects initial data from its SYNGAP1 clinical program in the first half of 2028, as the company prepares to begin dosing patients with a treatment designed to increase expression of a gene associated with a rare neurological disorder.
Chief Executive Officer Josh M
Via MarketBeat · November 9, 2026
Trade Desk Q3 Earnings Call Highlightsmarketbeat.com
Trade Desk (NASDAQ:TTD) reported third-quarter revenue of $736 million, down 0.5% from a year earlier but above its August outlook, as political advertising and demand from medical and health clients helped lift results.
The advertising technology company also benefited from a nonrecurring transact
Via MarketBeat · November 9, 2026
GeneDx Q3 Earnings Call Highlightsmarketbeat.com
GeneDx (NASDAQ:WGS) reported third-quarter revenue of $123.1 million and raised its full-year profitability outlook, even as new documentation requirements led the genetic testing company to lower its expectations for test volume growth.
Management said the company is requiring more payer documenta
Via MarketBeat · November 9, 2026
What Quantum Computing (QUBT) Said on Its Q3 Earnings Callmarketbeat.com
Quantum Computing (NASDAQ:QUBT) reported record third-quarter 2026 revenue of $9.5 million, driven primarily by its expanded photonics business, while its net loss widened as the company increased spending on personnel, research and commercialization.
Revenue rose from $384,000 a year earlier and e
Via MarketBeat · November 9, 2026
What Quantum (QMCO) Said on Its Q2 Earnings Callmarketbeat.com
Quantum (NASDAQ:QMCO) reported fiscal second-quarter revenue of $89.6 million, up 43% from a year earlier, as demand for its secondary storage products helped push its backlog to nearly $100 million.
The company also posted adjusted EBITDA of $11.1 million for the quarter ended September 30, 2026,
Via MarketBeat · November 9, 2026
WEBTOON Entertainment Q3 Earnings Call Highlightsmarketbeat.com
WEBTOON Entertainment (NASDAQ:WBTN) reported a 4% decline in third-quarter revenue as currency headwinds and weaker results in Japan offset growth in advertising and its Korean business. The company forecast a return to double-digit revenue growth on a constant-currency basis in the fourth quarter.
Via MarketBeat · November 9, 2026
Sanmina Q4 Earnings Call Highlightsmarketbeat.com
Sanmina (NASDAQ:SANM) forecast fiscal 2027 revenue of $17.5 billion to $19.5 billion as it begins shipping AMD’s Helios accelerated-compute systems and prepares to ramp additional cloud and artificial intelligence programs.
The outlook followed a fiscal fourth quarter in which revenue rose 84% from
Via MarketBeat · November 9, 2026
Qualys Q3 Earnings Call Highlightsmarketbeat.com
Qualys (NASDAQ:QLYS) reported 11% revenue growth for the third quarter of 2026 and raised its full-year earnings outlook, as federal customer wins helped drive a second consecutive quarter of double-digit growth in calculated current billings.
Revenue rose to $188 million, while non-GAAP earnings w
Via MarketBeat · November 9, 2026
What Hyperfine (HYPR) Said on Its Q3 Earnings Callmarketbeat.com
Hyperfine (NASDAQ:HYPR) reported record third-quarter revenue and gross margin, while narrowing its operating loss and reducing cash burn as sales of its portable brain MRI system increased across its U.S. and international markets.
Revenue rose 73% from a year earlier to $6 million for the quarter
Via MarketBeat · November 9, 2026
PubMatic Q3 Earnings Call Highlightsmarketbeat.com
PubMatic (NASDAQ:PUBM) reported 17% year-over-year revenue growth in the third quarter of 2026, marking its third consecutive quarter of accelerating growth as connected TV, mobile app advertising and newer products drove gains.
Adjusted EBITDA more than doubled to $26 million, with a margin of 33%
Via MarketBeat · November 9, 2026
What AbCellera Biologics (ABCL) Said on Its Q3 Earnings Callmarketbeat.com
AbCellera Biologics (NASDAQ:ABCL) plans to advance its experimental hot flash treatment ABCL635 into late-stage development in 2027 after reporting positive mid-stage results, while shelving further development of a separate antibody candidate for now.
On its third-quarter earnings call, the compan
Via MarketBeat · November 9, 2026
Clover Health Investments Sees 2027 Growth as Rival Exits New Jerseymarketbeat.com
Clover Health Investments (NASDAQ:CLOV) expects another year of strong membership growth in 2027, aided by a competitor’s exit from its core New Jersey market and what it sees as favorable positioning for its Medicare Advantage plans, Chief Financial Officer Clay Thornton said.
Thornton, recently a
Via MarketBeat · November 9, 2026
OraSure Technologies Q3 Earnings Call Highlightsmarketbeat.com
OraSure Technologies (NASDAQ:OSUR) reported 14% year-over-year revenue growth in the third quarter of 2026, but pushed back its target for operating cash flow breakeven as the timing of several product opportunities shifted.
The diagnostics and sample collection company now expects to reach operati
Via MarketBeat · November 9, 2026
Lucid Group Q3 Earnings Call Highlightsmarketbeat.com
Lucid Group (NASDAQ:LCID) reduced its free cash outflow by 30% in the third quarter of 2026 as the electric vehicle maker cut production, sold vehicles from inventory and continued a broader cost-reduction program.
The company reported revenue of $350 million, up 4% from a year earlier, and an adju
Via MarketBeat · November 9, 2026
Hallador Energy Q3 Earnings Call Highlightsmarketbeat.com
Hallador Energy (NASDAQ:HNRG) reported a third-quarter loss as lower coal sales and higher purchased-power costs weighed on results, while executives said they were working toward a year-end investment decision on the Turtle Creek gas power project.
The company reported a net loss of $4.5 million f
Via MarketBeat · November 9, 2026
Paysign Q3 Earnings Call Highlightsmarketbeat.com
Paysign (NASDAQ:PAYS) reported record third-quarter revenue, operating income and adjusted EBITDA as growth in its patient affordability business more than offset slower growth in plasma payment processing.
Revenue rose 42.6% from a year earlier to $30.8 million, while net income climbed to $6.7 mi
Via MarketBeat · November 9, 2026
iHeartMedia Q3 Earnings Call Highlightsmarketbeat.com
iHeartMedia (NASDAQ:IHRT) reported third-quarter revenue and adjusted earnings below its guidance as weakness in its broadcast radio business outweighed growth in podcasting and digital audio.
Revenue rose 3.3% from a year earlier to $1.03 billion, below the company’s forecast for mid-single-digit
Via MarketBeat · November 9, 2026
Kaltura Q3 Earnings Call Highlightsmarketbeat.com
Kaltura (NASDAQ:KLTR) reported record third-quarter revenue and raised its full-year outlook for the third time in 2026, as new subscription bookings more than doubled from the prior quarter and transactions involving its artificial intelligence products increased.
Revenue for the quarter ended Sep
Via MarketBeat · November 9, 2026
MARA Q3 Earnings Call Highlightsmarketbeat.com
MARA (NASDAQ:MARA) reported a sharp rise in third-quarter profit despite lower revenue, as gains in the value of its Bitcoin holdings boosted results. The company also outlined plans to expand its power portfolio and convert sites into artificial intelligence and high-performance computing infrastru
Via MarketBeat · November 9, 2026
What AST SpaceMobile (ASTS) Said on Its Q3 Earnings Callmarketbeat.com
AST SpaceMobile (NASDAQ:ASTS) reported $42.3 million in third-quarter revenue and reiterated its full-year 2026 revenue forecast, as it prepares to activate intermittent satellite service in the United States and other key markets before year-end.
The company also outlined plans to build its own re
Via MarketBeat · November 9, 2026
What Coherus Oncology (CHRS) Said on Its Q3 Earnings Callmarketbeat.com
Coherus Oncology (NASDAQ:CHRS) plans to cut approximately 30% of its workforce and focus development of its experimental drug tagmokitug on esophageal cancer as it seeks to reduce spending and grow sales of its cancer treatment LOQTORZI.
On its third-quarter 2026 earnings call, management said the
Via MarketBeat · November 9, 2026
What Definium Therapeutics (DFTX) Said on Its Q3 Earnings Callmarketbeat.com
Definium Therapeutics (NASDAQ:DFTX) plans to file a new drug application for its psychiatric treatment candidate DT120 ODT in the first half of 2027, following positive results from three Phase 3 studies in generalized anxiety disorder and major depressive disorder, executives said on the company’s
Via MarketBeat · November 9, 2026
Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in Focusmarketbeat.com
Danaher (NYSE:DHR) President and CEO Julie Sawyer Montgomery said the company is aiming for faster core growth and market share gains through stronger commercial execution, innovation and acquisitions, as it pursues a leadership position in life sciences and diagnostics.
Speaking at a UBS conferenc
Via MarketBeat · November 9, 2026
What Atea Pharmaceuticals (AVIR) Said on Its Q3 Earnings Callmarketbeat.com
Atea Pharmaceuticals (NASDAQ:AVIR) is targeting a mid-2027 U.S. application for its hepatitis C treatment, pending results from a second late-stage trial, and has secured a credit facility of up to $200 million to support its development and commercial plans.
On its third-quarter 2026 earnings call
Via MarketBeat · November 9, 2026
Goosehead Insurance Q3 Earnings Call Highlightsmarketbeat.com
Goosehead Insurance (NASDAQ:GSHD) reported higher third-quarter revenue and growth in its agent network, while disclosing plans to restate financial statements covering three years and the first half of 2026.
The insurance distributor said total revenue rose 17% year over year to approximately $110
Via MarketBeat · November 9, 2026
What Mesa Laboratories (MLAB) Said on Its Q2 Earnings Callmarketbeat.com
Mesa Laboratories (NASDAQ:MLAB) reported higher revenue and earnings for its fiscal 2027 second quarter and issued full-year guidance, while outlining plans to restructure its Clinical Genomics business and repurchase up to $40 million in shares.
The company expects fiscal 2027 revenue of $250 mill
Via MarketBeat · November 9, 2026
Better Home & Finance Q3 Earnings Call Highlightsmarketbeat.com
Better Home & Finance (NASDAQ:BETR) reported third-quarter revenue below its guidance and outlined plans to cut costs, expand home-equity lending and use artificial intelligence to improve productivity as it pursues adjusted EBITDA break-even.
The mortgage lender reported $45.1 million in total
Via MarketBeat · November 9, 2026
Amaero Q3 Earnings Call Highlightsmarketbeat.com
Amaero (NASDAQ:AMRO) reported 35% revenue growth in the third quarter of 2026 and forecast further gains in the final three months of the year, as it works to increase production following a safety-related pause at its Tennessee facility.
The metal powder and manufacturing company reported third-qu
Via MarketBeat · November 9, 2026
American Public Education Q3 Earnings Call Highlightsmarketbeat.com
American Public Education (NASDAQ:APEI) raised its full-year 2026 financial outlook after third-quarter revenue and earnings exceeded management’s guidance, as growth in nursing and military-affiliated programs helped offset higher marketing expenses and a revenue timing shift.
The education compan
Via MarketBeat · November 9, 2026
Digital Turbine Q2 Earnings Call Highlightsmarketbeat.com
Digital Turbine (NASDAQ:APPS) raised its fiscal 2027 revenue outlook after reporting 27% growth in its September quarter, but kept its adjusted earnings forecast unchanged as it plans further investment in data and artificial intelligence.
The mobile advertising company now expects annual revenue o
Via MarketBeat · November 9, 2026
What Coincheck Group (CNCK) Said on Its Q2 Earnings Callmarketbeat.com
Coincheck Group (NASDAQ:CNCK) reported a wider loss and a 43% decline in revenue for its second fiscal quarter as lower trading activity in Japan and an impairment tied to its Aplo subsidiary weighed on results.
The company is beginning to wind down Aplo as a separate European business and plans to
Via MarketBeat · November 9, 2026
AAON Q3 Earnings Call Highlightsmarketbeat.com
AAON (NASDAQ:AAON) raised its 2026 sales growth outlook after reporting record third-quarter revenue, as increased production and strong data center cooling demand helped it convert more of its backlog into sales.
The company also disclosed that it had restated its first- and second-quarter results
Via MarketBeat · November 9, 2026
What Senseonics Holdings, Inc. Common Stock (SENS) Said on Its Q3 Earnings Callmarketbeat.com
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) reported record third-quarter revenue and raised its 2026 sales outlook for the third time this year, as new patient starts for its Eversense 365 continuous glucose monitor drove growth in the United States and abroad.
Revenue rose approximately
Via MarketBeat · November 9, 2026
Corbus Pharmaceuticals Launches Phase 3 Cancer Trial, Teases More Obesity Drug Datamarketbeat.com
Corbus Pharmaceuticals (NASDAQ:CRBP) has started a Phase 3 study of its cancer drug CRB-701 and expects an exploratory readout from a separate frontline combination study in the first quarter of next year, CEO Yuval Cohen said at the Guggenheim Healthcare Innovation Conference.
Cohen also discussed
Via MarketBeat · November 9, 2026
Forward Air Q3 Earnings Call Highlightsmarketbeat.com
Forward Air (NASDAQ:FWRD) reported record quarterly revenue and nearly tripled its operating income in the third quarter of 2026, as stronger performance across its freight, logistics and intermodal businesses lifted margins.
Operating revenue rose to $674 million from $632 million a year earlier,
Via MarketBeat · November 9, 2026
What Lantronix (LTRX) Said on Its Q1 Earnings Callmarketbeat.com
Lantronix (NASDAQ:LTRX) reported fiscal first-quarter revenue of $32.4 million, up more than 8% from a year earlier, as growth in embedded computing products and unmanned systems helped offset softer sequential sales in its IoT system solutions business.
The company forecast revenue of $32.5 millio
Via MarketBeat · November 9, 2026
What Microvast (MVST) Said on Its Q3 Earnings Callmarketbeat.com
Microvast (NASDAQ:MVST) reported a steep drop in third-quarter revenue and a $76.8 million net loss as weaker commercial vehicle demand, inventory write-downs and asset impairments weighed on the battery manufacturer’s results.
Chief Financial Officer Rodney Worthen said revenue fell $77.5 million,
Via MarketBeat · November 9, 2026
What Trevi Therapeutics (TRVI) Said on Its Q3 Earnings Callmarketbeat.com
Trevi Therapeutics (NASDAQ:TRVI) said it remains on track to report results from its lead chronic cough trials in 2027 and 2028, while preparing a new study in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
On its third-quarter 2026 earnings call, the company also
Via MarketBeat · November 9, 2026